Partnership taps real-world data to accelerate clinical trials, research, and drug development in Japan. CAMBRIDGE, Mass., Feb. 12, 2025 /PRNewswire/ -- TriNetX, a global leader in real-world data ...
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals. CAMBRIDGE, Mass., Oct. 15, 2025 ...
Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but data compatibility, regulatory hurdles, and security concerns threaten to ...
CAMBRIDGE, Mass., Jan. 9, 2025 /PRNewswire/ -- TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company's Founder, President and CEO, will step down from ...
Recognition by The Healthcare Technology Report underscores TriNetX's innovation in real-world data, artificial intelligence, and clinical research transformation. TriNetX: Powering innovation across ...
TriNetX, the global health research network for healthcare organizations, biopharmaceutical companies, and Contract Research Organizations (CROs), announced the general availability of its Natural ...
Clinical trial data analysis company TriNetX has raised $40 million in a Series D funding round led by Merck Global Health Innovation Fund. Also participating in the round were new investors Mitsui & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results